Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Bronxville › NPI 1780196345
Hospital

The New York and Presbyterian Hospital

The New York and Presbyterian Hospital was paid $18.84M by Medicaid between Apr 2018 and Dec 2024, across 269 billing codes. Its largest line is 99283, emergency room visit (moderate) — 11% of everything it billed.

33Billing provider infoTHE NEW YORK AND PRESBYTERIAN HOSPITAL
BRONXVILLE, NY 10708
33aNPI1780196345assigned 11/03/2017
28Total paid$18.84M
24GClaims445,410
24DCodes billed269
24AFirst – last monthApr 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New York

Rank by total paid#63 of 231
Median peer was paid$561K
This provider vs. median34×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201810,208$217K
201944,499$1.06M
202087,641$2.13M
202184,508$2.95M
202272,315$3.97M
202381,473$4.79M
2024incomplete64,766$3.73M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 11% 11,921 11,334 $2.04M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 10% 11,939 11,590 $1.94M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 10% 12,104 11,609 $1.89M
96361 Intravenous infusion, hydration; each additional hour 9.2% 6,894 6,162 $1.74M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 4.7% 8,977 2,368 $879K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.9% 2,591 2,554 $741K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 3.8% 1,051 1,008 $709K
70450 Computed tomography, head or brain; without contrast material 3.7% 2,456 2,415 $691K
45380 Colonoscopy, flexible; with biopsy, single or multiple 3.3% 686 683 $630K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 2.8% 813 808 $529K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 2.8% 6,887 6,579 $520K
80053 Comprehensive metabolic panel 2.6% 25,385 23,288 $491K
257 more codes
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.0% 2,209 $377K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.7% 2,750 $326K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.7% 2,012 $318K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.5% 4,618 $275K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1.1% 5,975 $204K
99214 Doctor's office visit, returning patient (more involved) 1.0% 1,124 $189K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 2,658 $185K
97161 <1% 1,094 $145K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 735 $145K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 503 $143K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 912 $142K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 4,210 $134K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 5,286 $122K
86850 <1% 3,430 $114K
87486 <1% 2,689 $102K
80048 Basic metabolic panel (calcium, ionized) <1% 6,279 $100K
86901 <1% 4,414 $100K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 459 $98K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 364 $98K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 4,403 $86K
86900 <1% 4,455 $85K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,818 $77K
80076 <1% 3,208 $70K
84443 Thyroid stimulating hormone (TSH) <1% 6,992 $57K
99213 Doctor's office visit, returning patient (routine) <1% 353 $56K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 61 $55K
76830 Ultrasound, transvaginal <1% 1,520 $55K
83036 Hemoglobin; glycosylated (A1C) <1% 5,234 $54K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,979 $53K
87581 <1% 2,689 $52K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 2,693 $52K
83880 <1% 1,616 $51K
96375 Therapeutic injection; each additional sequential IV push <1% 5,077 $50K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 3,108 $50K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,284 $49K
99215 Doctor's office visit, returning patient (complex) <1% 314 $49K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 7,329 $47K
84702 <1% 4,649 $46K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,928 $45K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 25,899 $45K
87631 <1% 719 $44K
81401 <1% 208 $44K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,148 $41K
82607 <1% 3,260 $40K
80061 Lipid panel <1% 6,322 $39K
84439 <1% 5,159 $37K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 930 $36K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,111 $35K
59025 Fetal non-stress test <1% 138 $34K
82746 <1% 2,708 $33K
87086 Culture, bacterial; quantitative colony count, urine <1% 5,411 $31K
76819 Fetal biophysical profile; without non-stress testing <1% 1,436 $31K
86328 <1% 741 $30K
87480 <1% 1,976 $29K
36415 Collection of venous blood by venipuncture <1% 5,789 $28K
J3490 Unclassified drugs <1% 235 $28K
88307 <1% 581 $27K
81025 <1% 7,151 $26K
87660 <1% 2,057 $25K
87510 <1% 1,913 $23K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 1,422 $23K
77067 Screening mammography, bilateral, including computer-aided detection <1% 342 $23K
87340 <1% 2,325 $22K
82728 <1% 1,721 $22K
85610 <1% 7,323 $22K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 996 $22K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 36 $21K
71046 Radiologic examination, chest; 2 views <1% 4,479 $20K
86803 <1% 1,977 $20K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 334 $20K
86592 <1% 3,224 $19K
81243 <1% 382 $18K
84484 <1% 5,498 $18K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 128 $18K
85380 <1% 615 $16K
97116 <1% 440 $16K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 331 $16K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 459 $15K
86694 <1% 479 $15K
85730 <1% 6,177 $14K
76801 <1% 310 $14K
84152 <1% 596 $13K
81001 <1% 8,521 $13K
86618 <1% 360 $12K
86762 <1% 772 $12K
84146 <1% 546 $12K
83001 <1% 564 $11K
81329 <1% 117 $11K
83021 <1% 582 $11K
82803 <1% 308 $11K
83540 <1% 2,283 $11K
83550 <1% 2,268 $11K
86765 <1% 777 $10K
88342 <1% 127 $10K
76376 <1% 1,335 $9K
84403 <1% 310 $9K
83020 <1% 580 $8K
85027 <1% 3,072 $8K
83605 <1% 1,384 $8K
83002 <1% 404 $8K
71045 Radiologic examination, chest; single view <1% 2,343 $8K
J7120 Ringers lactate infusion, up to 1000 cc <1% 5,217 $7K
82670 <1% 236 $7K
93971 <1% 189 $7K
83735 <1% 2,786 $7K
J7050 Infusion, normal saline solution, 250 cc <1% 1,552 $7K
83690 <1% 5,124 $7K
81003 <1% 4,515 $7K
76813 <1% 334 $6K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 40 $6K
88312 <1% 598 $6K
82150 <1% 1,237 $6K
86140 <1% 1,783 $6K
72125 Computed tomography, cervical spine; without contrast material <1% 117 $6K
J7030 Infusion, normal saline solution , 1000 cc <1% 3,860 $6K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 24 $6K
87150 <1% 73 $5K
76942 <1% 56 $5K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 6,265 $5K
86480 <1% 106 $5K
71275 Computed tomographic angiography, chest, with contrast material <1% 13 $5K
86706 <1% 480 $5K
A9585 Injection, gadobutrol, 0.1 ml <1% 100 $5K
82550 <1% 1,212 $4K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 12 $4K
84402 <1% 161 $4K
36416 <1% 198 $4K
76641 <1% 151 $4K
82947 <1% 568 $4K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,570 $4K
90715 <1% 144 $4K
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation <1% 30 $4K
99203 Doctor's office visit, new patient (routine) <1% 21 $4K
95806 <1% 12 $4K
86704 <1% 335 $4K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 27 $3K
83525 <1% 243 $3K
86703 <1% 216 $3K
82950 <1% 604 $3K
C9290 Injection, bupivacaine liposome, 1 mg <1% 15 $3K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 13 $3K
85651 <1% 1,135 $3K
83655 <1% 165 $2K
99205 Prolong outpt/office vis <1% 14 $2K
84145 <1% 233 $2K
93000 <1% 2,019 $2K
87081 <1% 434 $2K
87070 <1% 653 $2K
87088 <1% 310 $2K
80320 <1% 620 $2K
76000 <1% 40 $2K
87186 <1% 558 $2K
82248 <1% 293 $2K
85007 <1% 1,244 $2K
85055 <1% 49 $2K
73610 <1% 193 $2K
82043 <1% 344 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,885 $2K
73630 <1% 219 $2K
82962 <1% 1,938 $1K
87430 <1% 339 $1K
96376 <1% 453 $1K
84100 <1% 797 $1K
J1756 Injection, iron sucrose, 1 mg <1% 32 $1K
84550 <1% 297 $1K
85379 <1% 1,213 $1K
83970 <1% 28 $1K
J2704 Injection, propofol, 10 mg <1% 4,215 $1K
86376 <1% 73 $1K
86431 <1% 206 $1K
82948 <1% 609 $1K
86756 <1% 134 $1K
77063 Screening digital breast tomosynthesis, bilateral <1% 115 $1K
72100 <1% 139 $1K
73030 <1% 199 $971.90
86038 <1% 185 $952.92
84153 <1% 49 $920.17
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 533 $904.37
86039 <1% 177 $903.46
97165 <1% 13 $877.66
86735 <1% 109 $864.74
82977 <1% 172 $837.56
77080 <1% 12 $815.00
86800 <1% 60 $802.85
88304 <1% 41 $777.70
86696 <1% 54 $767.08
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 680 $749.12
86787 <1% 94 $737.66
J0690 Injection, cefazolin sodium, 500 mg <1% 1,592 $674.91
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 4,848 $664.86
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,833 $640.33
J8540 Dexamethasone, oral, 0.25 mg <1% 242 $633.09
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 161 $605.80
82784 <1% 33 $578.66
76536 <1% 26 $570.00
86665 <1% 12 $566.00
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 906 $560.91
73560 <1% 115 $542.70
82627 <1% 25 $527.61
J3410 Injection, hydroxyzine hcl, up to 25 mg <1% 116 $516.34
84481 <1% 49 $441.58
83615 <1% 148 $421.57
87040 <1% 294 $368.80
82570 <1% 48 $349.94
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 6,148 $336.21
84155 <1% 135 $313.94
84436 <1% 85 $306.55
J7060 5% dextrose/water (500 ml = 1 unit) <1% 289 $303.71
J2270 Injection, morphine sulfate, up to 10 mg <1% 679 $291.53
85652 <1% 416 $272.01
84480 <1% 54 $269.05
J1170 Injection, hydromorphone, up to 4 mg <1% 928 $244.39
76642 <1% 13 $219.97
82533 <1% 12 $211.90
86235 <1% 13 $201.82
86695 <1% 30 $196.91
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,423 $146.21
85045 <1% 55 $143.80
86708 <1% 15 $136.50
84479 <1% 53 $124.76
86308 <1% 18 $118.00
86709 <1% 12 $111.50
87147 <1% 47 $105.08
82553 <1% 24 $99.14
82105 <1% 14 $93.46
87205 <1% 50 $87.23
82270 <1% 28 $76.66
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,522 $65.59
73130 <1% 26 $50.26
80179 <1% 53 $41.64
C1769 Guide wire <1% 28 $39.74
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 114 $32.90
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 519 $31.33
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program <1% 1,233 $30.22
J1644 Injection, heparin sodium, per 1000 units <1% 147 $29.97
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 354 $27.98
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 807 $24.22
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 741 $23.21
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 111 $19.23
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 517 $6.30
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 112 $3.58
80329 <1% 13 $2.24
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 14 $2.04
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 609 $1.39
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 116 $1.26
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram <1% 292 $0.80
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 110 $0.00
G0463 Hospital outpatient clinic visit for assessment and management of a patient 0% 14 $0.00
80050 General health panel 0% 514 $0.00
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml 0% 13 $0.00
99080 0% 1,444 $0.00
C9153 Injection, amisulpride, 1 mg 0% 20 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 12 $0.00
76857 0% 13 $0.00
J0184 Injection, amisulpride, 1 mg 0% 12 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 12 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 0% 44 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialFARRELL, WILLIAM (SENIOR VICE PRESIDENT, FINANCE)
Same official

Other billing entities under FARRELL, WILLIAM

Full network →
ProviderLocationPaid
Hudson Valley Hospital CenterCortlandt Manor, NY$15.87M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.